Building Expansion

To meet client and industry demand, we have undergone a large expansion project. This year Exelead has added two new Grade C formulations suites as well as a new filling line. The new modular filling line is a VarioSys Production System which includes a B+S filler and SKAN isolators.

Exelead Helps Manufacture Pfizer-BioNTech Covid-19 Vaccine

Pharmaceutical development and manufacturing company delivers first vaccine batch to Pfizer

Exelead Employees Encouraged to Take Election Day Off to Vote or Volunteer at the Polls

All team members will be allowed to take November 3rd off (with pay) to vote in the safest way possible.

 

Exelead Election Day

 

Keeping the Show on the Road Amid Supply Chain Disruptions

This article was originally published in The Medicine Maker. Contributor Kim Rice is Exelead's Director of Supply Chain & Project Management

DSC01036

Navigating Technology Transfer for LNP Formulations

This article was originally published in The Medicine Maker.

JF1_7168_web

The Rise of Lipid Nanoparticles

This article was originally published in The Medicine Maker.

LNP Formulations Exelead

Exelead set to double commercial manufacturing capacity by the end of 2020

With the rapid growth of personalized medicine and other technologies in the last five years, demand for liposomal drug products has reached an all time high. Due to the influx of business, we are excited to announce that we are beginning a large-scale expansion project that will allow us to meet industry demand and better serve our existing partners. 

 

DSC00741 (1)

Exelead Interns Host 5k Fundraiser for Little Red Door Cancer Agency

As part of their capstone project, this summer's crop of Exelead interns banded together to put on a 5k fundraiser for a locally-grown nonprofit. Little Red Door Cancer Agency works to reduce the physical, emotional and financial burdens of cancer for residents of central Indiana by providing free client services, cancer screenings and education.

 

Exelead Check Presentation

Liposomes and Lipid Nanoparticles as Delivery Vehicles for Personalized Medicine

At Exelead, we approach contract manufacturing with focused expertise on liposomal and PEGylated formulations to treat rare diseases and small or underserved populations. We specialize in the development and manufacture of lipid-based, parenteral drug products, and our team has more than 20 years' experience working with a wide range of preclinical, clinical and commercial contract manufacturing customers.

 

6 Specialties to Consider in Commercial Pharma Manufacturing

Finding the right biopharmaceutical manufacturer for your product can be quite a challenge. You need a company that has decades of experience, yet still values small batch productions just as much as large volume formulas.